An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib ...

The FDA approved three natural food additives. Food and nutrition experts share what that means for families and our food ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

Capricor's lead asset, deramiocel, targets DMD-related cardiomyopathy and faces key FDA milestones. Find out why CAPR stock ...

According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the ...

Combined data from Studies CL-QRX003-002 and CL-QRX003-003 is anticipated to provide QRX003 with the broadest possible label ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with ...

Eden, the leading health platform connecting individuals with independent licensed providers and pharmacies focused on metabolic health, today announced expanded access to female hormone therapy ...

The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says ...